NCT01306045 2024-10-01
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
4 trialsNCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
NCT00528281 2017-11-17
A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase
GlaxoSmithKline
Phase 1 Completed
NCT01218529 2014-12-31
Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors
Hellenic Cooperative Oncology Group
Phase 2 Completed